Lactoferrin in the central nervous system;Laktoferyna w ośrodkowym układzie nerwowym

Neurologia i Neurochirurgia Polska

Volumn 39, Issue 6, 2005, Pages 482-489

  Sacharczuk, Mariusz ^a   Zagulski, Tadeusz ^a   Sadowski, Bogdan ^a   Barcikowska, Maria ^b,c   Pluta, Ryszard ^b  

^a INSTITUTE OF GENETICS AND ANIMAL BREEDING   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^c NONE   (Poland)

Author keywords

Central nervous system; CNS; Lactoferrin; LF; Neurodegeneration

Indexed keywords

HYDROXYL RADICAL; LACTOFERRIN; OPIATE; PROTEIN P53; TRANSFERRIN;

ANIMAL BEHAVIOR; ANTIINFLAMMATORY ACTIVITY; BRAIN CANCER; CARCINOGENESIS; CENTRAL NERVOUS SYSTEM; DEGENERATIVE DISEASE; DNA DAMAGE; ECTODERM; GERIATRICS; HUMAN; IMMUNE SYSTEM; IMMUNITY; MENTAL STRESS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN STRUCTURE; REVIEW; STRUCTURE ANALYSIS; TISSUE DISTRIBUTION; TRANSACTIVATION; UPREGULATION;

ALZHEIMER DISEASE; BRAIN; CENTRAL NERVOUS SYSTEM; GENES, P53; HUMANS; LACTOFERRIN;

EID: 30344467813     PISSN: 00283843     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Groves M.L. The isolation of red protein from milk. J Am Chem Soc 1960; 82: 3345-3350.
2. Lambert L.A., Perri H., Meehan T.J. Evolution of duplications in the transferrin family of proteins. Comp Biochem Physiol B Biochem Mol Biol 2005; 140: 11-25.
3. Verbeek W., Lekstrom-Himes J., Park D.J. i wsp. Myeloid transcription factor C/EBPepsilon is involved in the positive regulation of lactoferrin gene expression in neutrophils. Blood 1999; 94: 3141-3150.
4. Kruzel M.L. Rola laktoferyny w rozwoju ostrych stanów zapalnych. Post Hig Med Dośw 2003; 57: 377-404.
5. Zagulski T., Lipinski P., Zagulska A. i wsp. Antibacterial system generated by lactoferrin in mice in vivo is primarily a killing system. Int J Exp Pathol 1998; 79: 117-123.
6. Qian Z.M., Wang Q. Expression of iron transport proteins and excessive iron accumulation in the brain in neurodegenerative disorders. Brain Res Brain Res Rev 1998; 27: 257-267.
7. Fillebeen C., Ruchoux M.M., Mitchell V. i wsp. Lactoferrin is synthesized by activated microglia in the human substantia nigra and its synthesis by the human microglial CHME cell line is upregulated by tumor necrosis factor alpha or 1-methyl-4-phenylpyridinium treatment. Brain Res Mol Brain Res 2001; 96: 103-113.
8. Poon H.F., Calabrese V., Scapagnini G. i wsp. Free radicals and brain aging. Clin Geriatr Med 2004; 20: 329-359.
9. Aguas A., Esaguy N., Sungel C.E. i wsp. The iron-binding protein lactotransferrin is present in pathologic lesions in a variety of neurodegenerative disorders: a comparative immunohistochemical analysis. Brain Res 1994; 650: 20-31.
10. Soti C., Csermely P. Chaperones and aging: role in neurodegeneration and in other civilizational diseases. Neurochem Int 2002; 41: 383-389.
11. Sacharczuk M. Zaburzenia procesu neurogenezy jako czynnik etiologiczny i objawowy chorób. W: Sacharczuk M. [red.]. Neurogeneza wieku dorosłego. Wyd. 1. Wydawnictwo Lekarskie PZWL, Warszawa 2005, ss. 59-68.
12. Calabrese V., Lodi R., Tonon C, i wsp. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia. J Neurol Sci 2005; 233: 145-162.
13. Fillebeen C., Descamps L., Dehouck M.P. i wsp. Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier. J Biol Chem 1999; 274: 7011-7017.
14. Terent A., Hallgren R., Venge P. Lactoferrin, lysozyme, and beta 2-microglobulin in cerebrospinal fluid. Elevated levels in patients with acute cerebrovascular lesions as indices of inflammation. Stroke 1981; 12: 40-46.
15. Guttenberg T.G., Flaegstad T., Jorgensen T. Lactoferrin, C-reactive protein, α-1-antitrypsin and immunoglobulin A in cerebrospinal fluid in meningitis. Acta Paediatr Scand 1986; 75: 569-572.
16. Pluta R. From brain ischemia-reperfusion injury to possible sporadic Alzheimer's disease. Curr Neurovasc Res 2004; 1: 441-453.
17. Griffin W.S., Sheng J.G., Royston M.C. i wsp. Glial-neuronal interactions in Alzheimer's disease: the potential role of a cytokine cycle in disease progression. Brain Pathol 1998; 8: 65-72.
18. Thornalley P.J. Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs. Cell Mol Biol 1998; 44: 1013-1023.
19. Leveugle B., Faucheux B.A., Bouras C. i wsp. Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson's disease cases. Acta Neuropathol (Berl) 1996; 91: 566-572.
20. Hallgren R., Venge P., Wistedt B. i wsp. Elevated serum levels of lactoferrin and eosinophil cationic protein in schizophrenic patients. Br J Psych 1982; 140: 55-60.
21. Fillebeen C., Mitchell V., Dexter D. i wsp. Lactoferrin is synthesized by mouse brain tissue and its expression is enhanced after MPTP treatment. Brain Res Mol Brain Res 1999; 72: 183-194.
22. Kawamata T., Tooyama I., Yamada T. i wsp. Lactotransferrin immunocytochemistry in Alzheimer and normal human brain. Am J Pathol 1993; 142: 1574-1585.
23. Weller M., List U., Schabet M. i wsp. Elevated CSF lactoferrin in superficial siderosis of the central nervous system. J Neurol 1999; 246: 943-945.
24. Tuccari G., Guiffre G., Crisafulli C. i wsp. Immunochemistry detection of lactoferrin in human astrocytmas and multiform glioblastomas. Eur J Histochem 1999; 43: 317-322.
25. Oh S.-M., Pyo C.-W., Kim Y. Neutrophil lactoferrin upregulates the human p53 gene through induction of NF-kappaB activation cascade. Oncogene 2004; 23: 8282-8291.
26. Mc Combs J.L., Teng C.T., Pentecost B.T. i wsp. Chromosomal localization of human lactotransferrin gene (LTF) by in situ hybridization. Cytogenet Cell Genet 1988; 47: 16-17.
27. Knight L.C. Non-oncologic applications of radiolabeled peptides in nuclear medicine. Q J Nucl Med 2003; 47: 279-291.
28. Nilsson M.R., Dobson C.M. In vitro characterization of lactoferrin aggregation and amyloid formation. Biochemistry 2003; 42: 375-382.
29. Pluta R. Alzheimer lesions after ischemia-reperfusion brain injury. Folia Neuropathol 2004; 42: 181-186.
30. Korytowski W., Sarna T., Zarba M. Antioxidant action of neuromelanin: the mechanism of inhibitory effect on lipid peroxidation. Arch Biochem Biophys 1995; 319: 142-148.
31. Double K.L., Gerlach M., Youdim M.B. i wsp. Impaired iron homeostasis in Parkinson's disease. J Neural Transm Suppl 2000; 60: 37-58.
32. Bertoli-Avella A.M., Oostra B.A., Heutink P. Chasing genes in Alzheimer's and Parkinson's disease. Hum Genet 2004; 114: 413-438.
33. Amouyel P. Genetic susceptibility to ageing-associated diseases. C R Biol 2002; 325: 741-745.
34. Clarke G., Lumsden C.J., McInnes R.R. Inherited neurodegenerative diseases: the one-hit model of neurodegeneration. Hum Mol Genet 2001; 10: 2269-2275.
35. Gabryelewicz T., Religa D., Styczynska M. i wsp. Behavioural pathology in Alzheimer's disease with special reference to apolipoprotein E genotype. Dement Geriatr Cogn Disord 2002; 14: 208-212.
36. Golebiowski M., Styczynska M., Pfeffer A. i wsp. Interaction evaluation between APOE epsilon 4 alleles and hippocampal atrophy. Preliminary communication. Neurol Neurochir Pol 2001; 35: 815-820.
37. Czyzewski K., Lalowski M.M., Pfeffer A. i wsp. Lipid metabolism parameters in patients with Alzheimer's disease and their first degree relatives. Acta Neurobiol Exp (Wars) 2001; 61: 21-26.
38. Fillebeen C., Dexter D., Mitchell V. i wsp. Lactoferrin is synthesized by mouse brain tissue and its expression is enhanced after MPTP treatment. Adv Exp Med Biol 1998; 443: 293-300.
39. Leenders K.L., Antonini A., Schwarzbach R. Blood to brain iron uptake in one rhesus monkey using [Fe-52]-citrate and positron emission tomography (PET): influence of haloperidol. J Neural Transm Suppl 1994; 43: 123-132.
40. Zimecki M., Artym J. Wpływ stresu psychicznego na odpowiedź immunologiczna. Post Hig Med Dośw 2004; 58: 166-175.
41. Takeuchi T., Hayashida K., Inagaki H. i wsp. Opioid mediated suppressive effect of milk-derived lactoferrin on distress induced by maternal separation in rat pups. Brain Res 2003; 979: 216-224.
42. Hayashida K.-I., Takeuchi T., Shimizu H. i wsp. Novel function of bovine milk-derived lactoferrin on antinociception mediated by μ-opioid receptor in the rat spinal cord. Brain Res 2003; 965: 239-245.
43. Kim S.J., Yu D.Y., Pak K.W. i wsp. Structure of the human lactoferrin gene and its chromosomal localization. Mol Cells 1998; 8: 663-668.
44. Liu L.H., Gladwell W., Teng C.T., Detection of exon polymorphisms in the human lactoferrin gene. Biochem Cell Biol 2002; 80: 17-22.
45. Borie C., Gasparini F., Verpillat P. i wsp. Association study between iron-related genes polymorphisms and Parkinson's disease. J Neurol 2002; 249: 801-804.
46. Sacharczuk M., Jaszczak K., Świergiel A.H. Funkcjonalne znaczenie redagowania transkryptów przez deaminaze adenozyny dwuniciowego RNA. Kosmos 2004; 53: 147-154.
47. Teng C., Gladwell W., Raphiou I. i wsp. Methylation and expression of the lactoferrin gene in human tissues and cancer cells. Biometals 2004; 17: 317-323.
48. Siebert P.D., Huang B.C.B. Identification of an alternative form of human lactoferrin mRNA that is expressed differentially in normal tissues and tumor-derived cell lines. Proc Natl Acad Sci USA 1997; 94: 2198-2203.